NewBio Enterprise Co., ltd.   Report issue

For profit
Founded: Japan (2009)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2014
NCT02300181
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

bacillus subtilis (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1